Carlo Salvarani
Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis.
Emmi G, Bettiol A, Gelain E, Bajema I, Berti A, Burns S, Cid M, Cohen Tervaert J, Cottin V, Durante E, Holle J, Mahr A, Del Pero M, Marvisi C, Mills J, Moiseev S, Moosig F, Mukhtyar C, Neumann T, Olivotto I, Salvarani C, Seeliger B, Sinico R, Taillé C, Terrier B, Venhoff N, Bertsias G, Guillevin L, Jayne D, Vaglio A. Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis. Nat Rev Rheumatol 2023; 19:378-393.
09.05.2023Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis.
09.05.2023Nat Rev Rheumatol 2023; 19:378-393
Emmi Giacomo, Bettiol Alessandra, Gelain Elena, Bajema Ingeborg M, Berti Alvise, Burns Stella, Cid María C, Cohen Tervaert Jan W, Cottin Vincent, Durante Eugenia, Holle Julia U, Mahr Alfred, Del Pero Marcos Martinez, Marvisi Chiara, Mills John, Moiseev Sergey, Moosig Frank, Mukhtyar Chetan, Neumann Thomas, Olivotto Iacopo, Salvarani Carlo, Seeliger Benjamin, Sinico Renato Alberto, Taillé Camille, Terrier Benjamin, Venhoff Nils, Bertsias George, Guillevin Loic, Jayne David R.W., Vaglio Augusto
Safety Profile of Upadacitinib up to 3 Years in Psoriatic Arthritis: An Integrated Analysis of Two Pivotal Phase 3 Trials
Burmester G, Liu J, Mccaskill R, Lertratanakul A, Lippe R, Lesser E, Rubbert-Roth A, Salvarani C, Azevedo V, Goupille P, Nash P, Blanco R, Winthrop K, Ruderman E. Safety Profile of Upadacitinib up to 3 Years in Psoriatic Arthritis: An Integrated Analysis of Two Pivotal Phase 3 Trials. Rheumatol Ther 2021
30.12.2021Safety Profile of Upadacitinib up to 3 Years in Psoriatic Arthritis: An Integrated Analysis of Two Pivotal Phase 3 Trials
30.12.2021Rheumatol Ther 2021
Burmester Gerd R, Liu John, Mccaskill Reva M, Lertratanakul Apinya, Lippe Ralph, Lesser Elizabeth, Rubbert-Roth Andrea, Salvarani Carlo, Azevedo Valderilio F, Goupille Philippe, Nash Peter, Blanco Ricardo, Winthrop Kevin, Ruderman Eric M
Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis (EGPA): a European multicenter observational study
European EGPA Study Group, Moroni L, Fagni F, Bello F, Fiori D, Ribi C, Cohen Tervaert J, Bargagli E, Samson M, Hellmich B, Mohammad A, Vacca A, Roccatello D, Ramirez G, Nasser M, Emmi G, Vaglio A, Prisco D, Jayne D, Salvarani C, Iannone F, Seeliger B, Egan A, Padoan R, Firinu D, Toniati P, Marvisi C, Fraticelli P, Cinetto F, Berti A, Lombardi C, Baldini C, Novikov P, Lopalco G, Neumann T, Schiavon F, Del Giacco S, Franceschini F, Cottin V, Dagna L, Urban M, Alberici F, Folci M, Crimi C, Silvagni E, Monti S, Kernder A, Schroeder J, Espígol-Frigolé G, Moosig F, Parronchi P, Lunardi C, Quartuccio L, Sinico R, Negrini S, Bettiol A. Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis (EGPA): a European multicenter observational study. Arthritis Rheumatol 2021
04.08.2021Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis (EGPA): a European multicenter observational study
04.08.2021Arthritis Rheumatol 2021
European EGPA Study Group, Moroni Luca, Fagni Filippo, Bello Federica, Fiori Davide, Ribi Camillo, Cohen Tervaert Jan Willem, Bargagli Elena, Samson Maxime, Hellmich Bernhard, Mohammad Aladdin J, Vacca Angelo, Roccatello Dario, Ramirez Giuseppe Alvise, Nasser Mouhamad, Emmi Giacomo, Vaglio Augusto, Prisco Domenico, Jayne David, Salvarani Carlo, Iannone Florenzo, Seeliger Benjamin, Egan Allyson, Padoan Roberto, Firinu Davide, Toniati Paola, Marvisi Chiara, Fraticelli Paolo, Cinetto Francesco, Berti Alvise, Lombardi Carlo, Baldini Chiara, Novikov Pavel, Lopalco Giuseppe, Neumann Thomas, Schiavon Franco, Del Giacco Stefano, Franceschini Franco, Cottin Vincent, Dagna Lorenzo, Urban Maria Letizia, Alberici Federico, Folci Marco, Crimi Claudia, Silvagni Ettore, Monti Sara, Kernder Anna Luise, Schroeder Jan, Espígol-Frigolé Georgina, Moosig Frank, Parronchi Paola, Lunardi Claudio, Quartuccio Luca, Sinico Renato Alberto, Negrini Simone, Bettiol Alessandra
Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss)
Papo M, Troilo A, Thiel J, Hellmich B, Monti S, Montecucco C, Salvarani C, Kahn J, Bonnotte B, Durel C, Puéchal X, Mouthon L, Guillevin L, Emmi G, Vaglio A, Terrier B, Jayne D, Barba T, Sinico R, Teixeira V, Venhoff N, Urban M, Iudici M, Mahrhold J, Locatelli F, Cassone G, Schiavon F, Seeliger B, Neumann T, Kroegel C, Groh M, Marvisi C, Samson M, French Vasculitis Study Group and the EGPA European Study Group. Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss). Rheumatology (Oxford) 2021; 60:4355-4360.
01.01.2021Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss)
01.01.2021Rheumatology (Oxford) 2021; 60:4355-4360
Papo Matthias, Troilo Arianna, Thiel Jens, Hellmich Bernhard, Monti Sara, Montecucco Carlomaurizio, Salvarani Carlo, Kahn Jean-Emmanuel, Bonnotte Bernard, Durel Cécile-Audrey, Puéchal Xavier, Mouthon Luc, Guillevin Loic, Emmi Giacomo, Vaglio Augusto, Terrier Benjamin, Jayne David, Barba Thomas, Sinico Renato A, Teixeira Vítor, Venhoff Nils, Urban Maria-Letizia, Iudici Michele, Mahrhold Juliane, Locatelli Francesco, Cassone Giulia, Schiavon Franco, Seeliger Benjamin, Neumann Thomas, Kroegel Claus, Groh Matthieu, Marvisi Chiara, Samson Maxime, French Vasculitis Study Group and the EGPA European Study Group
New perspectives in eosinophilic granulomatosis with polyangiitis (EGPA): report of the first meeting of the European EGPA Study Group
Marvisi C, Sinico R, Salvarani C, Jayne D, Prisco D, Terrier B, Emmi G, Vaglio A, European EGPA Study Group. New perspectives in eosinophilic granulomatosis with polyangiitis (EGPA): report of the first meeting of the European EGPA Study Group. Intern Emerg Med 2019; 14:1193-1197.
06.08.2019New perspectives in eosinophilic granulomatosis with polyangiitis (EGPA): report of the first meeting of the European EGPA Study Group
06.08.2019Intern Emerg Med 2019; 14:1193-1197
Marvisi Chiara, Sinico Renato Alberto, Salvarani Carlo, Jayne David, Prisco Domenico, Terrier Benjamin, Emmi Giacomo, Vaglio Augusto, European EGPA Study Group
A TNFSF13B functional variant is not involved in systemic sclerosis and giant cell arteritis susceptibility
González-Serna D, Boiardi L, Emmi G, Cimmino M, Vaglio A, Herrick A, Denton C, Salvarani C, Cid M, Morgan A, Fonseca C, González-Gay M, Martín J, Beretta L, Holle J, Neumann T, Carmona E, Ortego-Centeno N, Simeón C, Solans R, Hernández-Rodríguez J, Tolosa C, Castañeda S, Narváez J, Martinez-Valle F, European GCA Consortium, European Scleroderma Group, Witte T, Márquez A. A TNFSF13B functional variant is not involved in systemic sclerosis and giant cell arteritis susceptibility. PloS one 2018; 13:e0209343.
26.12.2018A TNFSF13B functional variant is not involved in systemic sclerosis and giant cell arteritis susceptibility
26.12.2018PloS one 2018; 13:e0209343
González-Serna David, Boiardi Luigi, Emmi Giacomo, Cimmino Marco A, Vaglio Augusto, Herrick Ariane L, Denton Christopher P, Salvarani Carlo, Cid María C, Morgan Ann W, Fonseca Carmen, González-Gay Miguel A, Martín Javier, Beretta Lorenzo, Holle Julia, Neumann Thomas, Carmona Elio G, Ortego-Centeno Norberto, Simeón Carmen P, Solans Roser, Hernández-Rodríguez José, Tolosa Carlos, Castañeda Santos, Narváez Javier, Martinez-Valle Ferran, European GCA Consortium, European Scleroderma Group, Witte Torsten, Márquez Ana